类风湿关节炎相关间质性肺病的外周血生物标志物特征
在退伍军人事务部类风湿关节炎注册队列的2001例RA患者中开展横断面研究,121例(6.4%)存在RA-ILD。主成分分析识别出15个生物标志物主成分,其中8个与RA-ILD独立相关;含主成分模型(AUC 0.739)及主成分联合MUC5B模型(AUC 0.751)均优于仅临床危险因素模型(AUC 0.630,P<0.001)。
要点
- 8个生物标志物主成分与RA-ILD相关,涉及先天与过敏反应、自身抗体、脂肪因子、警报素、组织重塑和中性粒细胞趋化。
- 含主成分模型AUC 0.739、联合MUC5B模型AUC 0.751,均优于仅临床危险因素模型AUC 0.630(P<0.001)。
- 外周血生物标志物特征可能有助于在临床危险因素之外改善RA-ILD识别与风险分层。
核心结论
- 外周血生物标志物特征与RA-ILD相关,并在临床危险因素之外改善RA-ILD识别。
- 这些发现提示RA-ILD发病机制涉及多种通路。
研究设计与样本
- 研究为横断面研究,对象为退伍军人事务部类风湿关节炎注册队列的参与者。
- 共纳入2001例RA患者,其中121例(6.4%)经系统病历审核确诊RA-ILD;88.7%为男性,平均年龄63.7岁。
- 检测了14种自身抗体、36种促炎细胞因子/趋化因子、3种脂肪因子、3种警报素和9种基质金属蛋白酶,并通过微阵列进行MUC5B rs35705950基因分型。
- 采用主成分分析提取生物标志物特征,并用逻辑回归比较包含临床、外周生物标志物和遗传变量的模型对RA-ILD的预测能力。
主要发现
- 共识别出15个主成分,校正临床因素后其中8个与RA-ILD显著相关。
- 这8个主成分涉及先天与过敏反应、自身抗体(抗环瓜氨酸肽抗体、类风湿因子、抗丙二醛-乙醛加合物抗体)、脂肪因子、警报素、组织重塑和中性粒细胞趋化等主题。
- 含主成分模型预测RA-ILD的AUC为0.739,主成分联合MUC5B模型AUC为0.751,均优于仅临床危险因素模型AUC 0.630(P<0.001)。
关键数值与推荐
- RA-ILD经系统病历审核验证。
- 含主成分模型AUC 0.739、联合MUC5B模型AUC 0.751,均优于仅临床危险因素模型AUC 0.630(P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a significant cause of morbidity and mortality among patients with RA, yet effective risk stratification for RA-ILD is lacking. We sought to characterize unique peripheral blood biomarker signatures in RA that could improve RA-ILD discrimination beyond clinical and genetic risk factors. METHODS: We performed a cross-sectional study of participants in the Veterans Affairs Rheumatoid Arthritis Registry. ILD was validated through systematic record review. Autoantibodies (n = 14), proinflammatory cytokines/chemokines (n = 36), adipokines (n = 3), alarmins (n = 3), and matrix metalloproteinases (n = 9) were measured from banked serum or plasma. MUC5B rs35705950 genotyping was obtained via microarray. Principal component (PC) analysis was performed to derive unique biomarker signatures. Logistic regression was used to compare models predicting RA-ILD presence using combinations of clinical, peripheral biomarker, and genetic variables. RESULTS: Among 2,001 participants with RA (88.7% male, mean age 63.7 years), 121 (6.4%) had RA-ILD. A total of 15 PCs were identified, with 8 significantly associated with RA-ILD after adjusting for clinical factors. These eight included biomarker themes of innate and allergic responses, autoantibodies (anti-cyclic citrullinated peptide, rheumatoid factor, anti-malondialdehyde-acetaldehyde adduct), adipokines, alarmins, tissue remodeling, and neutrophil chemotaxis. Models with PCs (area under the receiver operating characteristic curve [AUC] 0.739) and PCs with MUC5B (AUC 0.751) outperformed clinical risk factors alone (AUC 0.630; P < 0.001). CONCLUSION: Peripheral biomarker signatures are associated with RA-ILD and improve RA-ILD identification beyond clinical risk factors. In addition to demonstrating the potential for peripheral biomarkers to aid RA-ILD risk stratification, these findings suggest diverse pathways are involved in RA-ILD pathogenesis.
引用
- Wheeler AM, Baker JF, Riley TR, et al. Peripheral Biomarker Signatures in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2025. PMID: 40033001. doi:10.1002/art.43149
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。